IP Verse

Wockhardt competitive analysis

Latest patents of Wockhardt opposed by its competitors

Explore Wockhardt's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2326311
Jun 4, 2014Single Unit Oral Dose Pharmaceutical Composition Comprising Levodopa, Carbidopa And Entacapone Or Salts Thereof1
EP2328565
Jun 4, 2014An Extended Release Pharmaceutical Composition Of Entacapone Or Salts Thereof1

Latest PTAB cases involving Wockhardt

Discover the latest PTAB cases involving Wockhardt, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 19, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Wockhardt

IPR2016-01582Aug 10, 2016WOCKHARDT BIOAUERBACHFinal Written Decision
IPR2016-01582Aug 10, 2016WOCKHARDT BIOJANSSEN ONCOLOGYFinal Written Decision
IPR2016-01393Jul 8, 2016WOCKHARDT BIOELI LILLYFinal Written Decision
IPR2016-01335Jun 30, 2016WOCKHARDT BIOELI LILLYFinal Written Decision
IPR2016-01337Jun 30, 2016WOCKHARDT BIOELI LILLYFinal Written Decision
IPR2016-01029May 11, 2016WOCKHARDT BIOASTRAZENECAFinal Written Decision
IPR2016-01029May 11, 2016WOCKHARDT BIOASTRAZENECA ABFinal Written Decision
IPR2016-00370Dec 22, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSInstitution Denied
IPR2015-01813Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision
IPR2015-01814Aug 27, 2015WOCKHARDT BIOJAZZ PHARMACEUTICALSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Wockhardt with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WOCKHARDT BIO - - 12 -
ASTRAZENECA - 63 - 18
ELI LILLY18331715
JAZZ PHARMACEUTICALS - - - 23